APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Immunodeficiency Virus (HIV)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Immunodeficiency Virus (HIV) Industry Growth and Trends Forecast to 2032

31 December 2025100 pages

Choose your research edition.

Industry ResearchHuman Immunodeficiency Virus (HIV) Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Immunodeficiency Virus (HIV) Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Human Immunodeficiency Virus (HIV) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Immunodeficiency Virus (HIV) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Immunodeficiency Virus (HIV) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global Human Immunodeficiency Virus (HIV) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Immunodeficiency Virus (HIV) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Immunodeficiency Virus (HIV) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Immunodeficiency Virus (HIV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Human Immunodeficiency Virus (HIV) market include Merck & Co., Inc., Mylan, AbbVie, ViiV Healthcare, Genentech, Inc., Genentech, Inc., Cipla, Inc., Bristol-Myers Squibb Company and Boehringer Ingelheim GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Immunodeficiency Virus (HIV) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Immunodeficiency Virus (HIV) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Immunodeficiency Virus (HIV) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Immunodeficiency Virus (HIV).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Human Immunodeficiency Virus (HIV) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Immunodeficiency Virus (HIV) Market by Company

Merck & Co., Inc.

Mylan

AbbVie

ViiV Healthcare

Genentech, Inc.

Genentech, Inc.

Cipla, Inc.

Bristol-Myers Squibb Company

Boehringer Ingelheim GmbH

Boehringer Ingelheim GmbH

Human Immunodeficiency Virus (HIV) Segment by Type

Protease Inhibitors

NNRTIs

Coreceptor Antagonists

NRTIs

Entry and Fusion Inhibitors

Integrase Inhibitors

Human Immunodeficiency Virus (HIV) Segment by Application

Clinics

Hospitals

Labs

Human Immunodeficiency Virus (HIV) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Immunodeficiency Virus (HIV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Immunodeficiency Virus (HIV) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Immunodeficiency Virus (HIV).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Human Immunodeficiency Virus (HIV) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Human Immunodeficiency Virus (HIV) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Human Immunodeficiency Virus (HIV) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Human Immunodeficiency Virus (HIV) Market Share by Region (2021-2026) Table 4. Global Human Immunodeficiency Virus (HIV) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Human Immunodeficiency Virus (HIV) Market Share by Region (2027-2032) Table 6. Global Human Immunodeficiency Virus (HIV) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Human Immunodeficiency Virus (HIV) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Human Immunodeficiency Virus (HIV) Market Size Share by Type (2021-2026) Table 9. Global Human Immunodeficiency Virus (HIV) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Human Immunodeficiency Virus (HIV) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Human Immunodeficiency Virus (HIV) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Human Immunodeficiency Virus (HIV) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Human Immunodeficiency Virus (HIV) Market Size Share by Application (2021-2026) Table 24. Global Human Immunodeficiency Virus (HIV) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Human Immunodeficiency Virus (HIV) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Human Immunodeficiency Virus (HIV) Industry Trends Table 37. Human Immunodeficiency Virus (HIV) Industry Drivers Table 38. Human Immunodeficiency Virus (HIV) Industry Opportunities and Challenges Table 39. Human Immunodeficiency Virus (HIV) Industry Restraints Table 40. Global Human Immunodeficiency Virus (HIV) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Human Immunodeficiency Virus (HIV) Revenue Market Share by Company (2021-2026) Table 42. Global Human Immunodeficiency Virus (HIV) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Human Immunodeficiency Virus (HIV) Key Company Headquarters & Area Served Table 44. Global Human Immunodeficiency Virus (HIV) Company, Product Type & Application Table 45. Global Human Immunodeficiency Virus (HIV) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Human Immunodeficiency Virus (HIV) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Merck & Co., Inc. Company Information Table 49. Merck & Co., Inc. Business Overview Table 50. Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Product Portfolio Table 52. Merck & Co., Inc. Recent Development Table 53. Mylan Company Information Table 54. Mylan Business Overview Table 55. Mylan Human Immunodeficiency Virus (HIV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Mylan Human Immunodeficiency Virus (HIV) Product Portfolio Table 57. Mylan Recent Development Table 58. AbbVie Company Information Table 59. AbbVie Business Overview Table 60. AbbVie Human Immunodeficiency Virus (HIV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. AbbVie Human Immunodeficiency Virus (HIV) Product Portfolio Table 62. AbbVie Recent Development Table 63. ViiV Healthcare Company Information Table 64. ViiV Healthcare Business Overview Table 65. ViiV Healthcare Human Immunodeficiency Virus (HIV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ViiV Healthcare Human Immunodeficiency Virus (HIV) Product Portfolio Table 67. ViiV Healthcare Recent Development Table 68. Genentech, Inc. Company Information Table 69. Genentech, Inc. Business Overview Table 70. Genentech, Inc. Human Immunodeficiency Virus (HIV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Genentech, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio Table 72. Genentech, Inc. Recent Development Table 73. Genentech, Inc. Company Information Table 74. Genentech, Inc. Business Overview Table 75. Genentech, Inc. Human Immunodeficiency Virus (HIV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Genentech, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio Table 77. Genentech, Inc. Recent Development Table 78. Cipla, Inc. Company Information Table 79. Cipla, Inc. Business Overview Table 80. Cipla, Inc. Human Immunodeficiency Virus (HIV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Cipla, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio Table 82. Cipla, Inc. Recent Development Table 83. Bristol-Myers Squibb Company Company Information Table 84. Bristol-Myers Squibb Company Business Overview Table 85. Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Product Portfolio Table 87. Bristol-Myers Squibb Company Recent Development Table 88. Boehringer Ingelheim GmbH Company Information Table 89. Boehringer Ingelheim GmbH Business Overview Table 90. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Product Portfolio Table 92. Boehringer Ingelheim GmbH Recent Development Table 93. Boehringer Ingelheim GmbH Company Information Table 94. Boehringer Ingelheim GmbH Business Overview Table 95. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Product Portfolio Table 97. Boehringer Ingelheim GmbH Recent Development Table 98. North America Human Immunodeficiency Virus (HIV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2026) Table 101. North America Human Immunodeficiency Virus (HIV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Human Immunodeficiency Virus (HIV) Market Share Forecast by Country (2027-2032) Table 103. Europe Human Immunodeficiency Virus (HIV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2026) Table 106. Europe Human Immunodeficiency Virus (HIV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Human Immunodeficiency Virus (HIV) Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2026) Table 111. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share Forecast by Country (2027-2032) Table 113. Latin America Human Immunodeficiency Virus (HIV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2026) Table 116. Latin America Human Immunodeficiency Virus (HIV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Human Immunodeficiency Virus (HIV) Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2026) Table 121. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Human Immunodeficiency Virus (HIV) Product Image Figure 3. Global Human Immunodeficiency Virus (HIV) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Human Immunodeficiency Virus (HIV) Market Size (2021-2032) & (US$ Million) Figure 5. Global Human Immunodeficiency Virus (HIV) Market Share by Region: 2025 VS 2032 Figure 6. Global Human Immunodeficiency Virus (HIV) Market Share by Region (2021-2032) Figure 7. North America Human Immunodeficiency Virus (HIV) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Human Immunodeficiency Virus (HIV) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Human Immunodeficiency Virus (HIV) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Protease Inhibitors Image Figure 13. Global Protease Inhibitors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. NNRTIs Image Figure 15. Global NNRTIs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Coreceptor Antagonists Image Figure 17. Global Coreceptor Antagonists Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. NRTIs Image Figure 19. Global NRTIs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Entry and Fusion Inhibitors Image Figure 21. Global Entry and Fusion Inhibitors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Integrase Inhibitors Image Figure 23. Global Integrase Inhibitors Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global Human Immunodeficiency Virus (HIV) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global Human Immunodeficiency Virus (HIV) Market Share by Type 2025 VS 2032 Figure 26. North America Human Immunodeficiency Virus (HIV) Market Size Share by Type (2021-2032) Figure 27. Europe Human Immunodeficiency Virus (HIV) Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Share by Type (2021-2032) Figure 29. Latin America Human Immunodeficiency Virus (HIV) Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size Share by Type (2021-2032) Figure 31. Clinics Image Figure 32. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Hospitals Image Figure 34. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Labs Image Figure 36. Global Labs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Human Immunodeficiency Virus (HIV) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Human Immunodeficiency Virus (HIV) Market Share by Application 2025 VS 2032 Figure 39. North America Human Immunodeficiency Virus (HIV) Market Size Share by Application (2021-2032) Figure 40. Europe Human Immunodeficiency Virus (HIV) Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Share by Application (2021-2032) Figure 42. Latin America Human Immunodeficiency Virus (HIV) Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Human Immunodeficiency Virus (HIV) Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Human Immunodeficiency Virus (HIV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Human Immunodeficiency Virus (HIV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032) Figure 49. Europe Human Immunodeficiency Virus (HIV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Human Immunodeficiency Virus (HIV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032) Figure 52. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032) Figure 55. Latin America Human Immunodeficiency Virus (HIV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Human Immunodeficiency Virus (HIV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032) Figure 58. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Human Immunodeficiency Virus (HIV) Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Protease Inhibitors
  • NNRTIs
  • Coreceptor Antagonists
  • NRTIs
  • Entry and Fusion Inhibitors
  • Integrase Inhibitors
Applications
  • Clinics
  • Hospitals
  • Labs
Companies covered
  • Merck & Co., Inc.
  • Mylan
  • AbbVie
  • ViiV Healthcare
  • Genentech, Inc.
  • Genentech, Inc.
  • Cipla, Inc.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim GmbH
  • Boehringer Ingelheim GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Human Immunodeficiency Virus (HIV) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Human Immunodeficiency Virus (HIV) Market Size by Region (2021-2032)
  5. 1.4.1 Global Human Immunodeficiency Virus (HIV) Market Size by Region (2021-2026)
  6. 1.4.2 Global Human Immunodeficiency Virus (HIV) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Human Immunodeficiency Virus (HIV) Market Size (2021-2032)
  8. 1.5.1 North America Human Immunodeficiency Virus (HIV) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Human Immunodeficiency Virus (HIV) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Human Immunodeficiency Virus (HIV) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Growth Rate (2021-2032)
2 Human Immunodeficiency Virus (HIV) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Protease Inhibitors
  3. 2.1.2 NNRTIs
  4. 2.1.3 Coreceptor Antagonists
  5. 2.1.4 NRTIs
  6. 2.1.5 Entry and Fusion Inhibitors
  7. 2.1.6 Integrase Inhibitors
  8. 2.2 Global Human Immunodeficiency Virus (HIV) Market Size by Type
  9. 2.2.1 Global Human Immunodeficiency Virus (HIV) Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global Human Immunodeficiency Virus (HIV) Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global Human Immunodeficiency Virus (HIV) Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global Human Immunodeficiency Virus (HIV) Market Size by Regions
  13. 2.3.1 North America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size Breakdown by Type (2021-2026)
3 Human Immunodeficiency Virus (HIV) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Clinics
  3. 3.1.2 Hospitals
  4. 3.1.3 Labs
  5. 3.2 Global Human Immunodeficiency Virus (HIV) Market Size by Application
  6. 3.2.1 Global Human Immunodeficiency Virus (HIV) Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Human Immunodeficiency Virus (HIV) Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Human Immunodeficiency Virus (HIV) Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Human Immunodeficiency Virus (HIV) Market Size by Regions
  10. 3.3.1 North America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Human Immunodeficiency Virus (HIV) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Human Immunodeficiency Virus (HIV) Industry Trends
  2. 4.2 Human Immunodeficiency Virus (HIV) Industry Drivers
  3. 4.3 Human Immunodeficiency Virus (HIV) Industry Opportunities and Challenges
  4. 4.4 Human Immunodeficiency Virus (HIV) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Human Immunodeficiency Virus (HIV) Revenue (2021-2026)
  2. 5.2 Global Human Immunodeficiency Virus (HIV) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Human Immunodeficiency Virus (HIV) Key Company Headquarters & Area Served
  4. 5.4 Global Human Immunodeficiency Virus (HIV) Company, Product Type & Application
  5. 5.5 Global Human Immunodeficiency Virus (HIV) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Human Immunodeficiency Virus (HIV) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Human Immunodeficiency Virus (HIV) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Human Immunodeficiency Virus (HIV) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Merck & Co., Inc.
  2. 6.1.1 Merck & Co., Inc. Company Information
  3. 6.1.2 Merck & Co., Inc. Business Overview
  4. 6.1.3 Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co., Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
  6. 6.1.5 Merck & Co., Inc. Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Human Immunodeficiency Virus (HIV) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Human Immunodeficiency Virus (HIV) Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 AbbVie
  14. 6.3.1 AbbVie Company Information
  15. 6.3.2 AbbVie Business Overview
  16. 6.3.3 AbbVie Human Immunodeficiency Virus (HIV) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 AbbVie Human Immunodeficiency Virus (HIV) Product Portfolio
  18. 6.3.5 AbbVie Recent Developments
  19. 6.4 ViiV Healthcare
  20. 6.4.1 ViiV Healthcare Company Information
  21. 6.4.2 ViiV Healthcare Business Overview
  22. 6.4.3 ViiV Healthcare Human Immunodeficiency Virus (HIV) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ViiV Healthcare Human Immunodeficiency Virus (HIV) Product Portfolio
  24. 6.4.5 ViiV Healthcare Recent Developments
  25. 6.5 Genentech, Inc.
  26. 6.5.1 Genentech, Inc. Company Information
  27. 6.5.2 Genentech, Inc. Business Overview
  28. 6.5.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Genentech, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
  30. 6.5.5 Genentech, Inc. Recent Developments
  31. 6.6 Genentech, Inc.
  32. 6.6.1 Genentech, Inc. Company Information
  33. 6.6.2 Genentech, Inc. Business Overview
  34. 6.6.3 Genentech, Inc. Human Immunodeficiency Virus (HIV) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Genentech, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
  36. 6.6.5 Genentech, Inc. Recent Developments
  37. 6.7 Cipla, Inc.
  38. 6.7.1 Cipla, Inc. Company Information
  39. 6.7.2 Cipla, Inc. Business Overview
  40. 6.7.3 Cipla, Inc. Human Immunodeficiency Virus (HIV) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Cipla, Inc. Human Immunodeficiency Virus (HIV) Product Portfolio
  42. 6.7.5 Cipla, Inc. Recent Developments
  43. 6.8 Bristol-Myers Squibb Company
  44. 6.8.1 Bristol-Myers Squibb Company Company Information
  45. 6.8.2 Bristol-Myers Squibb Company Business Overview
  46. 6.8.3 Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Bristol-Myers Squibb Company Human Immunodeficiency Virus (HIV) Product Portfolio
  48. 6.8.5 Bristol-Myers Squibb Company Recent Developments
  49. 6.9 Boehringer Ingelheim GmbH
  50. 6.9.1 Boehringer Ingelheim GmbH Company Information
  51. 6.9.2 Boehringer Ingelheim GmbH Business Overview
  52. 6.9.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Product Portfolio
  54. 6.9.5 Boehringer Ingelheim GmbH Recent Developments
  55. 6.10 Boehringer Ingelheim GmbH
  56. 6.10.1 Boehringer Ingelheim GmbH Company Information
  57. 6.10.2 Boehringer Ingelheim GmbH Business Overview
  58. 6.10.3 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Boehringer Ingelheim GmbH Human Immunodeficiency Virus (HIV) Product Portfolio
  60. 6.10.5 Boehringer Ingelheim GmbH Recent Developments
7 North America
  1. 7.1 North America Human Immunodeficiency Virus (HIV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026)
  3. 7.3 North America Human Immunodeficiency Virus (HIV) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Human Immunodeficiency Virus (HIV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026)
  3. 8.3 Europe Human Immunodeficiency Virus (HIV) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Human Immunodeficiency Virus (HIV) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Human Immunodeficiency Virus (HIV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026)
  3. 10.3 South America Human Immunodeficiency Virus (HIV) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Human Immunodeficiency Virus (HIV) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst